Pfizer-BioTech seek COVID-19 vaccine approval for children in Europe

Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies' coronavirus vaccine to include children ages 12 to 15.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

Hometown Heroes in New York City

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Hometown Heroes in Connecticut

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines